CRL vs FOXXW · rev $2.00B vs rev $65.9M
Charles River Laboratories (CRL) versus Foxx Development Holdings Inc. (FOXXW) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Foxx Development Holdings Inc. (FOXXW) common stock listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported FOXXW revenue for 2025-06-30 was $65.9M. Net income was -$9.0M. Revenue was up 1941.8% from 2024-06-30 to 2025-06-30. FOXXW currently screens at market cap $0.
CRL currently screens at market cap $7.78B. FOXXW currently screens at market cap $0.
Not investment advice. Open the CRL and FOXXW stock pages for the full models.
Not investment advice.